METIRRA

Medicines; medical preparations for the treatment of cancer; pharmaceutical and veterinary preparations and substances; biological preparations and substances for medical use; diagnostic biomarker reagents for medical purposes; diagnostic biomarkers for in vitro testing for medical use; diagnostic biomarkers for use in assessment of genomic analysis for medical use; diagnostic biomarkers for use in assessment of chemical skin sensitizers for medical use; diagnostic biomarkers for use in assessment of toxicological property of chemical compounds and mixtures for medical use; biopharmaceuticals for the treatment of cancer; biotechnological preparations for medical purposes; biotechnological preparations for medical use; biocides; diagnostic biomarkers for use in assessment of chemical respiratory sensitizers for medical use; diagnostic reagents and assays for detecting antigens for medical purposes; biotherapeutics; biosimilars; immunotherapeutic agents for cancer; biomarkers and antibodies used in medical imaging.

Diagnosis of diseases; medical analysis for the diagnosis and treatment of persons; disease diagnosis services; medical analysis services for the diagnosis and treatment of persons; medical analysis services for cancer diagnosis and prognosis; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical services; healthcare consultancy services [medical services]; medical consultancy services; provision of information in the field of cancer prevention, screening, diagnosis and treatment; RNA or DNA analysis for cancer diagnosis and prognosis; pathology services; oncology (medical services); services for the preparation of medical reports; information, advisory and consultancy services in relation to the aforementioned.